Methods for using vasopressin antagonists with chemotherapeutic agents to reduce anthracycline cardiotoxicity and / or improving survival

摘要

Tolvaptan or a pharmaceutically acceptable salt thereof for use in a method of reducing cardiotoxicity and / or improving survival from doxorubicin chemotherapy wherein tolvaptan or a pharmaceutically acceptable salt thereof is administered simultaneously or before administration of doxorubicin.